Company / Current Assets
Sunshine Biopharma Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$26.9M
FY2025
5-year range
$2.2M / $27.3M
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $58,460 in FY2016 to $27M in FY2022.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +92.1%.
Improved from $25M to $27M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- +92.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +92.1%, indicating consistent growth.
- In FY2025, current assets increased 3.4% year-over-year.
- Peak current assets was recorded in FY2022.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.9M | +3.4% |
| FY2024 | $26.0M | +4.3% |
| FY2023 | $24.9M | -8.9% |
| FY2022 | $27.3M | +1143.8% |
| FY2021 | $2.2M | +114.0% |
| FY2020 | $1.0M | +1461.9% |
| FY2019 | $65.7K | -68.9% |
| FY2018 | $211.5K | +80.5% |
| FY2017 | $117.2K | +100.5% |
| FY2016 | $58.5K | +8.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026